Equipment Upgrade- next gen MiSeq 100

The contract involves an equipment upgrade focused on enhancing the efficiency and specificity of sequenced products by implementing the next-generation MiSeq 100 system. This initiative is associated with the Food and Drug Administration (FDA) and falls under the NAICS code 541990, which pertains to specialized scientific and technical services. The upgrade aims to improve the precision and throughput of sequencing operations, contributing to better research and regulatory outcomes. The contract was forecasted on March 11, 2026, and while key administrative details such as the solicitation number and specific location of performance remain unspecified, the Food and Drug Administration will oversee the project. Points of contact include an acquisition liaison reachable via email, with the contracting officer yet to be assigned. The opportunity is publicly accessible for industry review through the FDA's online forecast platform.